» Articles » PMID: 17156142

Etiology of New-onset Jaundice: How Often is It Caused by Idiosyncratic Drug-induced Liver Injury in the United States?

Overview
Specialty Gastroenterology
Date 2006 Dec 13
PMID 17156142
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: The epidemiology of acute drug-induced liver injury (DILI) in the United States has not been well studied. We conducted a study of adults with new-onset jaundice at a nonreferral community hospital to better understand the epidemiology of acute DILI.

Methods: This is a retrospective study of adult outpatients and inpatients (> or =18 yr) with new-onset jaundice over a 5-yr period (1999-2003) at Wishard Memorial Hospital, Indiana. Patients with new-onset jaundice were identified using our electronic medical record system and individual medical records were reviewed to extract the required clinical data. New-onset jaundice was defined as the presence of total serum bilirubin >3 mg/dL in patients without a prior total bilirubin >3 mg/dL.

Results: A total of 732 eligible adults constituted our study cohort. Sepsis or altered hemodynamic state resulting in presumed ischemic liver injury is the single most common cause of jaundice (22%). Acute liver disease as a result of nonalcoholic etiologies caused new-onset jaundice in 97 patients (13%), with acute viral hepatitis in 66 patients (9%) and DILI in 29 patients (4%). Most cases of DILI were as a result of acetaminophen toxicity with idiosyncratic DILI occurring in only five patients (0.7%). No mortality was observed at 6 wk in patients who developed idiosyncratic DILI.

Conclusion: Idiosyncratic DILI appears to be a rare cause of new-onset jaundice in a community hospital setting.

Citing Articles

Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update.

Mao Y, Ma S, Liu C, Liu X, Su M, Li D Hepatol Int. 2024; 18(2):384-419.

PMID: 38402364 DOI: 10.1007/s12072-023-10633-7.


InterDILI: interpretable prediction of drug-induced liver injury through permutation feature importance and attention mechanism.

Lee S, Yoo S J Cheminform. 2024; 16(1):1.

PMID: 38173043 PMC: 10765872. DOI: 10.1186/s13321-023-00796-8.


A computational study to identify Sesamol derivatives as NRF2 activator for protection against drug-induced liver injury (DILI).

Mili A, Birangal S, Nandakumar K, Lobo R Mol Divers. 2023; 28(3):1709-1731.

PMID: 37392347 PMC: 11269468. DOI: 10.1007/s11030-023-10686-8.


An Immunological Perspective on the Mechanism of Drug Induced Liver Injury: Focused on Drugs for Treatment of Hepatocellular Carcinoma and Liver Transplantation.

Lee S, Choi J, Jung E, Kwon J, Jang J, Bae S Int J Mol Sci. 2023; 24(5).

PMID: 36902432 PMC: 10003078. DOI: 10.3390/ijms24055002.


Liver Damage and microRNAs: An Update.

Cione E, Guandique D, Caroleo M, Luciani F, Colosimo M, Cannataro R Curr Issues Mol Biol. 2023; 45(1):78-91.

PMID: 36661492 PMC: 9857663. DOI: 10.3390/cimb45010006.